Research Labs
-
Focusing on genetic and molecular basis of antimalarial drug resistance in P. falciparum, antimalarial drug discovery, genetically attenuated parasite vaccines, parasite lipid metabolism.
-
The Goff lab studies the life cycle of retroviruses, and performs screens to identify and characterize restriction factors that inhibit virus replication and the host factors that they require.
-
The Guo Lab uses bioinformatics to study immune responses to pandemic and disease-related viruses, focusing on countermeasures for pandemic preparedness and antibody therapies for various diseases.
-
The Ho Lab is committed to finding scientific solutions to end the HIV/AIDS pandemic and using the techniques acquired in their decades of HIV research to the novel coronavirus SARS-CoV-2.
-
The Iketani Lab is focused on developing scalable strategies that contribute to answering basic and translational virology questions, particularly for pandemic preparedness and virological discovery.
-
The Kwong-Shapiro Lab focuses on structural vaccinology to advance antibody therapeutics and vaccines. Their research has contributed to the design of vaccines against HIV-1, influenza A, and RSV.
-
The Meyers lab addresses health inequity by accelerating translation of scientific discoveries into public health interventions accessible to marginalized populations, with a particular focus on HIV.
-
The focus of the Sabo Lab is to expand our understanding of cellular host factors and their interaction with specific infecting viral pathogens: HIV-1 and the human respiratory syncytial virus (HRSV).
-
The goal of the Sheng Lab is to use interdisciplinary approaches to understand the mechanisms of antibody maturation and disease etiology, and to find therapeutic targets for disease prevention.
-
The Small-Saunders Lab investigates novel epigenetic and epitranscriptomic aspects of drug resistance and stress tolerance in Plasmodium falciparum parasites.
-
Dr. Sobieszczyk’s major investigative interest is the treatment and prevention of HIV and SARS-CoV-2.
-
The Tsuji Lab's research projects are applied and translational, seeking to further understanding of host immune system for development of effective vaccines against infectious diseases and cancer.
-
The Uhlemann Lab studies the evolution of drug resistance in bacteria and the relationship between intestinal microbiome and colonization with multi-drug resistant organisms.
-
The focus of the Wu Lab is to elucidate the mechanisms by which the HIV-1 envelope glycoprotein elicits neutralizing antibody responses in humans and rhesus macaques for HIV-1 vaccine development.
-
The Yamashita Lab studies the biology of human immunodeficiency virus to elucidate the fundamental principles of viral replication and to develop novel drug design strategies.
-
Dr. Yin’s research focuses on antiretroviral treatments for HIV and investigating non-infectious complications of HIV infeciton.
